Family · Pharmaceutical analytical standards

Colistimethate

A prodrug of colistin (polymyxin E) in which sulphomethyl groups make the molecule less toxic when injected; available since 1959, it is given intravenously or by inhalation against multidrug-resistant Gram-negative bacteria, often as a last resort. This family brings together the active ingredient.

Did you know?Colistin was isolated in Japan in the late 1940s from a culture of Bacillus polymyxa var. colistinus; largely abandoned in the 1980s, it came back into use in the 1990s against multidrug-resistant bacteria.

Go to the active ingredient →

Active ingredientColistimethate SodiumCat. No. P-C244-001CAS 8068-28-8

EDQM standards 4

The official European Pharmacopoeia standards for this family.

Reference substanceColistimethate sodium CRSEDQM code C2600000Family Colistimethate

Structure not applicable: mixtureFor peak identificationColistimethate sodium for peak identification CRSEDQM code Y0001888Family Colistimethate

Structure not applicable: mixtureFor peak identificationE1 colistimethate sodium for peak identification CRSEDQM code Y0001887Family Colistimethate

Structure not applicable: mixtureFor peak identificationE2 colistimethate sodium for peak identification CRSEDQM code Y0001886Family Colistimethate

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.

See our services Contact us